| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $28K | -81.7% |
| R&D Expense | $5.8M | +56.8% |
| SG&A Expense | $6.8M | +594.3% |
| Operating Income | -$12.6M | -168.6% |
| Pre-tax Income | -$16.5M | -225.2% |
| Income Tax | $10K | -68.8% |
| Net Income | -$16.5M | -223.4% |
| EPS (Basic) | $26.36 | -40.4% |
| EPS (Diluted) | $26.36 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -74.2% |
| Current Assets | $2.3M | -54.8% |
| Total Assets | $2.9M | -45.5% |
| Current Liabilities | $3.5M | +60.4% |
| Total Liabilities | $6.9M | +203.9% |
| Stockholders' Equity | -$4.0M | +74.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.4M | -85.4% |
| Capital Expenditures | $22K | +83.3% |
| Investing Cash Flow | -$22K | -103.8% |
| Financing Cash Flow | $5.1M | +877.8% |
| Free Cash Flow | -$8.4M | -85.4% |
| -40.4% |